Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - ABEONA THERAPEUTICS INC. | Financial_Report.xls |
10-K - FORM 10-K - ABEONA THERAPEUTICS INC. | v405690_10k.htm |
EX-32 - EXHIBIT 32 - ABEONA THERAPEUTICS INC. | v405690_exh32.htm |
EX-21 - EXHIBIT 21 - ABEONA THERAPEUTICS INC. | v405690_exh21.htm |
EX-10.29 - EXHIBIT 10.29 - ABEONA THERAPEUTICS INC. | v405690_ex10-29.htm |
EX-31.1 - EXHIBIT 31.1 - ABEONA THERAPEUTICS INC. | v405690_exh31x1.htm |
EX-31.2 - EXHIBIT 31.2 - ABEONA THERAPEUTICS INC. | v405690_exh31x2.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 31, 2015, accompanying the consolidated financial statements included in the Annual Report of PlasmaTech Biopharmaceuticals, Inc. and subsidiaries on Form 10-K for the years ended December 31, 2014 and 2013. We hereby consent to the incorporation by reference of said report in the Registration Statements of PlasmaTech Biopharmaceuticals, Inc. on Form S-1 (File Nos. 333-197220, 333-179603, 333-178415, 333-166453, 333-162687, 333-149633, and 333-135734), Form S-4 (File No. 333-143587), and Form S-8 (File Nos. 333-189985, 333-169067, 333-161642, 333-75136, 333-125796, and 333-114269).
/s/ Whitley Penn LLP Dallas, Texas March 31, 2015 |